New method to detect histone acetylation levels by flow cytometry

Cytometry Part A

Volumn 66, Issue 1, 2005, Pages 52-61

  Ronzoni, Simona ^a   Faretta, Mario ^a   Ballarini, Marco ^a   Pelicci, PierGiuseppe ^a   Minucci, Saverio ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Flow cytometry; Histone acetylation; Histone deacetylase inhibitor; Leukemia

Indexed keywords

DNA; HISTONE; HISTONE DEACETYLASE INHIBITOR; MONOCLONAL ANTIBODY; RETINOIC ACID; TRICHOSTATIN A; VALPROIC ACID;

ACETYLATION; ARTICLE; BLOOD SAMPLING; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIVISION; CHROMATIN; CONTROLLED STUDY; DNA DETERMINATION; DNA REPLICATION; DNA TRANSCRIPTION; EPILEPSY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ACETYLATION; ACUTE DISEASE; ANALYSIS OF VARIANCE; BLOOD CELLS; CELL LINE, TUMOR; FLOW CYTOMETRY; HISTONE DEACETYLASES; HISTONES; HUMANS; LEUKEMIA; TUMOR MARKERS, BIOLOGICAL;

EID: 20944441116     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20151     Document Type: Article

References (23)

1. Berger SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev 2002;12:142-148.
2. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293: 1074-1080.
3. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature 1997;389:349-352.
4. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 1999;98:285-294.
5. Minucci S, Pelicci PG. Retinoid receptors in health and disease: coregulators and the chromatin connection. Semin Cell Dev Biol 1999; 10:215-225.
6. Gelmetti V, Zhang J, Fanelli M, Minucci S, Pelicci PG, Lazar MA. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 1998;18:7185-7191.
7. Faretta M, Di Croce L, Pelicci PG. Effects of the acute myeloid leukemia-associated fusion proteins on nuclear architecture. Semin Hematol 2001;38:42-53.
8. Minucci S, Maccarana M, Cioce M, De Luca P, Gelmetti V, Segalla S, Di Croce L, Giavara S, Matteucci C, Gobbi A, et al. Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol Cell 2000;5:811-820.
9. Minucci S, Nervi C, Lo Coco F, Pelicci PG. Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene 2001;20:3110-3115.
10. Alcalay M, Orleth A, Sebastiani C, Meani N, Chiaradonna F, Casciari C, Sciurpi MT, Gelmetti V, Riganelli D, Minucci S, et al. Common themes in the pathogenesis of acute myeloid leukemia. Oncogene 2001; 20:5680-5694.
11. Warrell RP Jr, He LZ, Richon V, Calleja E, Pandolfi PP. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J Natl Cancer Inst 1998;90:1621-1625.
12. Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002;1:287-299.
13. Turner BM. Cellular memory and the histone code. Cell 2002;111: 285-291.
14. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999;401:188-193.
15. Halicka HD, Bedner E, Darzynkiewicz Z. Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis. Exp Cell Res 2000;260:248-256.
16. Jensen PO, Larsen J, Larsen JK. Flow cytometric measurement of RNA synthesis based on bromouridine labelling and combined with measurement of DNA content or cell surface antigen. Acta Oncol 1993;32:521-524.
17. Jensen PO, Larsen J, Christiansen J, Larsen JK. Flow cytometric measurement of RNA synthesis using bromouridine labelling and bromodeoxyuridine antibodies. Cytometry 1993;14:455-458.
18. Jensen PO, Larsen J, Larsen JK. Analysis of RNA synthesis by cytometry. Methods Cell Biol 2001;64:129-138.
19. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991;77: 1080-1086.
20. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001;20:6969-6978.
21. Taddei A, Roche D, Sibarita JB, Turner BM, Almouzni G. Duplication and maintenance of heterochromatin domains. J Cell Biol 1999;147: 1153-1166.
22. Rountree MR, Bachman KE, Baylin SB. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 2000;25:269-277.
23. Jasencakova Z, Meister A, Walter J, Turner BM, Schubert I. Histone H4 acetylation of euchromatin and heterochromatin is cell cycle dependent and correlated with replication rather than with transcription. Plant Cell 2000;12:2087-2100.